Gagnon Securities
TECH icon

Gagnon Securities’s Bio-Techne TECH Stock Holding History

Gagnon Securities’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-12,230
Closed -$864K – 89
2026
Q2 		$864K Buy
12,230
+2,351
+24% +$127K 0.17% 49
2026
Q1 		$516K Buy
9,879
+265
+3% +$15.9K 0.12% 57
2025
Q4 		$565K Hold
9,614
– – 0.12% 58
2025
Q3 		$535K Buy
9,614
+344
+4% +$18.4K 0.11% 58
2025
Q2 		$477K Buy
9,270
+327
+4% +$16.4K 0.1% 60
2025
Q1 		$524K Buy
8,943
+1,085
+14% +$73.5K 0.12% 58
2024
Q4 		$566K Buy
7,858
+489
+7% +$35.9K 0.11% 59
2024
Q3 		$589K Buy
7,369
+253
+4% +$19K 0.12% 57
2024
Q2 		$510K Buy
7,116
+82
+1% +$6.04K 0.11% 58
2024
Q1 		$495K Buy
7,034
+2,170
+45% +$155K 0.12% 60
2023
Q4 		$375K Buy
4,864
+932
+24% +$61.4K 0.09% 61
2023
Q3 		$268K Buy
+3,932
New +$311K 0.07% 75

Other funds holding TECH

Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Geneva Capital Management
Geneva Capital Management Milwaukee, Wisconsin $3.59B AUM 12.18% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Gagnon Securities's TECH Position: Q3 2026 in Review

Gagnon Securities sold out of Bio-Techne (TECH) in Q3 2026, closing a stake of 12,230 shares — an estimated $864K sold.

Gagnon Securities first reported a position in TECH in Q3 2023 and held it in 12 quarters. The position peaked at $864K in Q2 2026. 301 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Gagnon Securities reported no remaining Bio-Techne position as of Q3 2026 after selling out during the quarter.
  • Gagnon Securities sold 12,230 Bio-Techne shares in Q3 2026, an estimated $864K.
  • Gagnon Securities first reported a position in Bio-Techne in Q3 2023 and held it in 12 quarters.
  • Gagnon Securities's Bio-Techne position peaked at $864K in Q2 2026.
  • 301 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Gagnon Securities's 13F filing for Q3 2026, filed 5 Nov 2026.